Ligand validation:6O9V

TMO: trimethylamine oxide

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6O9V_TMO_A_401	7%	46%	0.334	0.796	1.9	0.23	3	-	0	0	100%	0.85
6O9V_TMO_B_403	2%	46%	0.383	0.64	1.9	0.23	3	-	0	0	100%	0.62
7N9L_TMO_A_405	8%	46%	0.372	0.847	1.9	0.23	3	-	0	0	100%	1
4XZ6_TMO_B_401	97%	1%	0.065	0.98	7.46	0.48	4	-	0	0	100%	1
4A0T_TMO_B_1554	94%	60%	0.075	0.976	1.23	0.29	1	-	0	0	100%	1
6W9G_TMO_M_301	90%	3%	0.093	0.975	6.36	0.2	1	-	0	0	100%	1
6B1B_TMO_A_602	88%	47%	0.097	0.972	1.91	0.18	1	-	0	0	100%	1
3T29_TMO_A_261	88%	46%	0.068	0.942	1.76	0.39	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.